Induces apoptosis in cancer cells; inhibits CXCL12-mediated migration of chronic lymphocytic leukemia (CLL) cells upon CXCR4 activation; exhibits anti-tumor activity in models of acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma.